There’s a new twist in the fight against bladder cancer — and it’s delivering game-changing results. In a recent clinical ...

In August 2025, Seagen announced a studies how well tucatinib works for solid tumors that make either more HER2 or a ...

During a live event, Nataliya Mar, MD, discussed systemic therapies such as lenvatinib/pembrolizumab in advanced renal cell ...

The field of genitourinary (GU) oncology has seen significant developments over recent decades, yet challenges in treatment outcomes remain. Current ...